selegiline has been researched along with reserpine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Axelsson, S; Inoue, O; Långström, B; Lundqvist, H; Oreland, L | 1 |
| Cohen, G | 1 |
| Blinc, M; Dernovsek, M; Sket, D | 1 |
| Fagervall, I; Ross, SB | 1 |
| Bretton, C; Hof, P; Ofori, S; Schorderet, M | 1 |
| Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
| Greenshaw, AJ; Juorio, AV; Wishart, TB | 1 |
| Fozard, JR; Palfreyman, MG; Robin, M; Zreika, M | 1 |
| Dènes, B; Greeff, K; Tawfik, H | 1 |
| Biassoni, R; Vaccari, A | 1 |
| Azmitia, EC; Gu, XF | 1 |
| Diavolitsis, P; Dringenberg, HC; Laporte, PP | 1 |
| Bruce, A; Dringenberg, HC; Rubenstein, ML; Solty, H; Tomaszek, S | 1 |
| Liu, HQ; Weng, EQ; Zhu, XZ | 1 |
| Cano, J; de Pablos, RM; Herrera, AJ; Machado, A; Navarro, A; Santiago, M; Tomás-Camardiel, M; Villarán, RF | 1 |
| Bhutani, MK; Bishnoi, M; Kulkarni, SK | 1 |
| Mishra, N; Sasmal, D | 1 |
1 review(s) available for selegiline and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for selegiline and reserpine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl.
Topics: Animals; Brain; Carbon Radioisotopes; Male; Methamphetamine; Mice; Reserpine; Selegiline; Tissue Distribution; Tomography, Emission-Computed | 1990 |
Monoamine oxidase and oxidative stress at dopaminergic synapses.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Glutathione; Glutathione Reductase; Haloperidol; In Vitro Techniques; Levodopa; Male; Mice; Monoamine Oxidase; Oxidation-Reduction; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stress, Physiological; Substantia Nigra; Synapses; Synaptosomes | 1990 |
In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat.
Topics: Animals; Clorgyline; Female; Histocytochemistry; Locus Coeruleus; Microscopy, Fluorescence; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Inbred Strains; Reserpine; Selegiline | 1989 |
Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
Topics: Animals; Brain; Clorgyline; Dose-Response Relationship, Drug; Hydrazines; Hypothalamus; Iproniazid; Male; Monoamine Oxidase Inhibitors; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Serotonin; Reserpine; Selegiline; Tranylcypromine | 1986 |
Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and L-DOPA decarboxylase and monoamine oxidase inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Pargyline; Rabbits; Reserpine; Retina; Selegiline; Tyrosine | 1986 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
Topics: Animals; Biogenic Amines; Clorgyline; Corpus Striatum; Dopamine; Male; Mice; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Reserpine; Selegiline | 1988 |
The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
Topics: Allylamine; Amines; Animals; Body Temperature; Brain; Electric Stimulation; Hemodynamics; Hydroxydopamines; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Oxidopamine; Phenethylamines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Spinal Cord; Sympathectomy, Chemical; Sympathetic Nervous System; Tyramine | 1985 |
Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors.
Topics: Anesthesia; Animals; Blood Pressure; Cats; Dose-Response Relationship, Drug; Hemodynamics; Humans; Monoamine Oxidase Inhibitors; Myocardial Contraction; Pargyline; Reserpine; Selegiline; Stereoisomerism; Tranylcypromine | 1983 |
Gonadal influences on the inhibition of monoamine oxidase type B activity.
Topics: Animals; Blepharoptosis; Body Temperature; Estradiol; Female; Hypothalamus; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Ovary; Phenethylamines; Rats; Reserpine; Selegiline; Testis | 1982 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Increased effectiveness of tacrine by deprenyl co-treatment in rats: EEG and behavioral evidence.
Topics: Animals; Cerebral Cortex; Cholinesterase Inhibitors; Drug Synergism; Electroencephalography; Male; Maze Learning; Monoamine Oxidase Inhibitors; Rats; Rats, Long-Evans; Reserpine; Scopolamine; Selegiline; Tacrine | 2000 |
Electroencephalographic activation by tacrine, deprenyl, and quipazine: cholinergic vs. non-cholinergic contributions.
Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Electroencephalography; Monoamine Oxidase Inhibitors; Muscarinic Antagonists; Prosencephalon; Quipazine; Rats; Rats, Long-Evans; Reserpine; Scopolamine; Selegiline; Serotonin Antagonists; Tacrine | 2002 |
Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Dopamine; L-Lactate Dehydrogenase; Lactic Acid; Monoamine Oxidase Inhibitors; Oxidation-Reduction; PC12 Cells; Rats; Reactive Oxygen Species; Reserpine; Rotenone; Selegiline | 2005 |
Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Topics: alpha-Methyltyrosine; Animals; Apoptosis; Astrocytes; Cell Respiration; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; gamma-Aminobutyric Acid; Male; Microglia; Mitochondria; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurons; Nitro Compounds; Nomifensine; Oxygen Consumption; Propionates; Rats; Rats, Wistar; Reactive Oxygen Species; Reserpine; Selegiline; Succinate Dehydrogenase; Superoxides; Synaptosomes; Tyrosine 3-Monooxygenase; Up-Regulation | 2008 |
Antidepressant activity of curcumin: involvement of serotonin and dopamine system.
Topics: Alkaloids; Animals; Antidepressive Agents; Behavior, Animal; Benzodioxoles; Biogenic Monoamines; Biological Availability; Curcumin; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Immobility Response, Tonic; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Polyunsaturated Alkamides; Reserpine; Selegiline; Serotonin; Swimming; Time Factors; Tranylcypromine | 2008 |
Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor.
Topics: Amines; Animals; Behavior, Animal; Brain; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Pyrazolones; Reserpine; Selegiline; Stereotyped Behavior | 2012 |